ArticleStatistics in medicine2026
Examining the Efficacy of Coarsened Exact Matching as an Alternative to Propensity Score Matching.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Coarsened exact matching (CEM) is often promoted as a superior alternative to propensity score matching (PSM) for addressing imbalance, model dependence, bias, and efficiency. However, this recommendation remains uncertain. First, CEM is commonly mischaracterized as exact matching, despite relying on coarsened rather than original variables. This inexactness in matching introduces residual confounding, which necessitates accurate modeling of the outcome-confounder relationship post-matching to mitigate bias, thereby increasing vulnerability to model misspecification. Second, prior studies overlook that any imbalance between treated and untreated subjects matched on the same propensity score is attributable to random variation. Thus, claims that CEM outperforms PSM in reducing imbalance are unfounded, particularly when using metrics like Mahalanobis distance, which do not account for chance imbalance in PSM. Our simulations show that PSM reduces imbalance more effectively than CEM when evaluated with multivariate standardized mean differences (SMD), and unadjusted analyses indicate greater bias with CEM. While adjusted analyses in both CEM with autocoarsening and PSM may perform similarly when matching on a few variables, CEM suffers from the curse of dimensionality as the number of factors increases, resulting in substantial data loss and unstable estimates. Increasing the level of coarsening may mitigate data loss but exacerbates residual confounding and model dependence. In contrast, both analytical results and simulations demonstrate that PSM is more robust to model misspecification and thus less model-dependent. Therefore, CEM is not a viable alternative to PSM when matching on a large number of covariates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.